ANGPT1 and Duchenne muscular dystrophy: Considering VEGF’s enhancement of mini-dystrophin gene therapy efficacy [8] and Ang 1’s anti-inflammatory properties, Ang 1 may prove invaluable as an adjunct vascular-therapeutic agent for treating DMD.